We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+13.09%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
AUM
$2.8B
AUM Growth
+$275M
Cap. Flow
-$353K
Cap. Flow %
-0.01%
Top 10 Hldgs %
42.5%
Holding
432
New
15
Increased
84
Reduced
148
Closed
20

Top Buys

Rank Stock Value
1
TT icon
Trane Technologies
TT
+$26.7M
2
NKE icon
Nike
NKE
+$25.7M
3
UNP icon
Union Pacific
UNP
+$23.1M
4
ADP icon
Automatic Data Processing
ADP
+$22.1M
5
ETN icon
Eaton
ETN
+$21.5M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$62.8M
2
LUV icon
Southwest Airlines
LUV
+$40.8M
3
DIS icon
Walt Disney
DIS
+$34.8M
4
MMM icon
3M
MMM
+$23.8M
5
NFLX icon
Netflix
NFLX
+$7.09M

Sector Composition

Rank Sector Weight
1 Technology 22.83%
2 Industrials 15.68%
3 Healthcare 11.85%
4 Consumer Discretionary 10.85%
5 Communication Services 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLDP
126
Ballard Power Systems
BLDP
$796M
$816K 0.03%
65,000
-5,000
-7% -$75.6K
LUV icon
127
Southwest Airlines
LUV
$24B
$809K 0.03%
18,895
-868,331
-98% -$40.8M
ALB icon
128
Albemarle
ALB
$14.1B
$807K 0.03%
3,450
+2,150
+165% +$532K
UL icon
129
Unilever
UL
$139B
$807K 0.03%
13,333
PEP icon
130
PepsiCo
PEP
$189B
$805K 0.03%
4,637
-530
-10% -$86.6K
EXPE icon
131
Expedia Group
EXPE
$38B
$803K 0.03%
4,445
RIO icon
132
Rio Tinto
RIO
$165B
$803K 0.03%
12,000
DFAU icon
133
Dimensional US Core Equity Market ETF
DFAU
$12.8B
$801K 0.03%
24,260
+12,735
+110% +$409K
GSK icon
134
GSK
GSK
$103B
$798K 0.03%
14,480
-1,600
-10% -$83.2K
INTC icon
135
Intel
INTC
$515B
$797K 0.03%
15,484
-500
-3% -$25.6K
HWM icon
136
Howmet Aerospace
HWM
$116B
$796K 0.03%
25,000
MRNA icon
137
Moderna
MRNA
$22.5B
$790K 0.03%
3,111
YETI icon
138
Yeti Holdings
YETI
$3.96B
$788K 0.03%
9,515
-1,485
-14% -$136K
U icon
139
Unity
U
$15.4B
$787K 0.03%
5,505
+1,005
+22% +$154K
CNH
140
CNH Industrial
CNH
$13.5B
$777K 0.03%
45,960
-11,490
-20% -$176K
AZN icon
141
AstraZeneca
AZN
$250B
$776K 0.03%
6,663
-1,000
-13% -$118K
JPM icon
142
JPMorgan Chase
JPM
$958B
$773K 0.03%
4,880
+1,000
+26% +$164K
CMBS icon
143
iShares CMBS ETF
CMBS
$473M
$769K 0.03%
14,494
+1,043
+8% +$55.8K
TD icon
144
Toronto Dominion Bank
TD
$201B
$767K 0.03%
10,000
-2,000
-17% -$146K
CNQ icon
145
Canadian Natural Resources
CNQ
$94.6B
$761K 0.03%
36,756
-4,084
-10% -$82.6K
SONY icon
146
Sony
SONY
$132B
$758K 0.03%
30,000
-7,500
-20% -$179K
ADSK icon
147
Autodesk
ADSK
$50.2B
$754K 0.03%
2,683
+1,300
+94% +$379K
SPGI icon
148
S&P Global
SPGI
$121B
$751K 0.03%
1,591
+400
+34% +$183K
RY icon
149
Royal Bank of Canada
RY
$294B
$743K 0.03%
7,000
-1,000
-13% -$104K
DHI icon
150
D.R. Horton
DHI
$42.3B
$729K 0.03%
6,725
-65
-1% -$6.26K

Similar funds

R.H. Bluestein & Co's Q4 2021 Portfolio in Review

As of Q4 2021, R.H. Bluestein & Co held 432 positions worth $2.8B, up 11% from $2.52B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

R.H. Bluestein & Co's Q4 2021 filing shows 15 new, 84 increased, 148 reduced and 20 closed positions. Its largest new stake was Rivian: 6,490 shares worth $673K. The largest sale was Dollar General, an estimated $62.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

  • R.H. Bluestein & Co's largest Q4 2021 buy was Rivian: 6,490 shares worth $673K.
  • R.H. Bluestein & Co added most to Trane Technologies in Q4 2021, an estimated $26.7M increase.
  • R.H. Bluestein & Co's biggest Q4 2021 reduction was Dollar General, cutting an estimated $62.8M.
  • R.H. Bluestein & Co fully exited Sonos in Q4 2021, selling an estimated $744K.
  • R.H. Bluestein & Co's ten largest holdings make up 42% of its $2.8B portfolio in Q4 2021.
  • R.H. Bluestein & Co opened 15 new positions and closed 20 in Q4 2021.
  • R.H. Bluestein & Co's portfolio value rose 11% quarter-over-quarter to $2.8B.

Based on R.H. Bluestein & Co's 13F filing for Q4 2021, filed 14 Feb 2022.